Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Biomarker and diagnostic research for non-arteritic anterior ischemic optic neuropathy has been reported in the published literature.
2 clinical trials registered, 2 recruiting. Interventions under study include drug therapy, other interventions, and gene therapy. Pipeline includes 1 PHASE3, 1 PHASE1. Research is primarily industry-sponsored.
214 publications have been identified in PubMed for non-arteritic anterior ischemic optic neuropathy. Research spans Epidemiology / Natural History (25%), Case Report / Case Series (19%), and Review / Meta-Analysis (18%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 53 |
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 1:01 AM UTC
European rare disease database
Patient case studies | 40 | 19% |
Research summaries | 39 | 18% |
Laboratory research | 27 | 13% |
Clinical study results | 19 | 9% |
Testing and diagnosis research | 17 | 8% |
Other research | 16 | 7% |
New treatment approaches | 3 | 1% |
Liu Z (2026). [PMID: 41475544](https://pubmed.ncbi.nlm.nih.gov/41475544/). *Ophthalmology*. [Review / Meta-Analysis]
Tseng YH (2026). [PMID: 40987377](https://pubmed.ncbi.nlm.nih.gov/40987377/). *Survey of ophthalmology*. [Case Report / Case Series]
Lampsas S (2026). [PMID: 42193383](https://pubmed.ncbi.nlm.nih.gov/42193383/). *Biomedicines*. [Review / Meta-Analysis]
Finsterer J (2026). [PMID: 41839257](https://pubmed.ncbi.nlm.nih.gov/41839257/). *Diabetes & metabolism*. [Epidemiology / Natural History]
Sharma A (2026). [PMID: 41666351](https://pubmed.ncbi.nlm.nih.gov/41666351/). *Ophthalmic surgery, lasers & imaging retina*. [Basic Science / Preclinical]
Chan SH (2026). [PMID: 41453566](https://pubmed.ncbi.nlm.nih.gov/41453566/). *Diabetes research and clinical practice*. [Clinical Trial Publication]
Sensoy E (2026). [PMID: 41795612](https://pubmed.ncbi.nlm.nih.gov/41795612/). *Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti*. [Case Report / Case Series]
Williams ZR (2026). [PMID: 41544737](https://pubmed.ncbi.nlm.nih.gov/41544737/). *Am J Ophthalmol*. [Clinical Trial Publication]
Unknown (2026). [PMID: 42133961](https://pubmed.ncbi.nlm.nih.gov/42133961/). *J Neuroophthalmol*. [Review / Meta-Analysis]
Asensio-Sánchez VM (2026). [PMID: 41796736](https://pubmed.ncbi.nlm.nih.gov/41796736/). *Archivos de la Sociedad Espanola de Oftalmologia*. [Basic Science / Preclinical]
AI-curated news mentioning non-arteritic anterior ischemic optic neuropathy
Updated Feb 23, 2026
A study published in PubMed highlights the use of orbital MRI as a diagnostic tool for giant cell arteritis in patients with anterior ischaemic optic neuropathy. This research could enhance diagnostic accuracy and improve patient outcomes.
A systematic review and meta-analysis investigates the association between semaglutide and the risk of non-arteritic ischemic optic neuropathy. The findings contribute to understanding the safety profile of this medication in patients.
A recent study investigates the occurrence of new-onset nonarteritic anterior ischemic optic neuropathy among US veterans initiating treatment with semaglutide for type 2 diabetes. The findings contribute to understanding potential ocular complications associated with diabetes treatments.
FDA has approved the first human trial of Life Biosciences' ER-100, a gene therapy aimed at rejuvenating retinal cells in patients with age-related eye diseases. This Phase 1 study will focus on conditions such as open-angle glaucoma and non-arteritic anterior ischemic optic neuropathy (NAION).